- Home
- WORX vs AWH Comparison
WORX vs AWH Comparison
Compare WORX & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- AWH
- Stock Information
- Founded
- WORX N/A
- AWH 1993
- Country
- WORX United States
- AWH United States
- Employees
- WORX N/A
- AWH N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- AWH Medical/Dental Instruments
- Sector
- WORX Consumer Discretionary
- AWH Health Care
- Exchange
- WORX Nasdaq
- AWH Nasdaq
- Market Cap
- WORX N/A
- AWH 1.6M
- IPO Year
- WORX N/A
- AWH N/A
- Fundamental
- Price
- WORX $0.66
- AWH $0.10
- Analyst Decision
- WORX
- AWH Buy
- Analyst Count
- WORX 0
- AWH 2
- Target Price
- WORX N/A
- AWH $4.40
- AVG Volume (30 Days)
- WORX 31.4K
- AWH 12.9M
- Earning Date
- WORX 11-14-2024
- AWH 03-27-2025
- Dividend Yield
- WORX N/A
- AWH N/A
- EPS Growth
- WORX N/A
- AWH N/A
- EPS
- WORX N/A
- AWH N/A
- Revenue
- WORX $3,224,146.00
- AWH $9,182,000.00
- Revenue This Year
- WORX N/A
- AWH $11.87
- Revenue Next Year
- WORX N/A
- AWH $79.10
- P/E Ratio
- WORX N/A
- AWH N/A
- Revenue Growth
- WORX N/A
- AWH 0.31
- 52 Week Low
- WORX $0.67
- AWH $0.08
- 52 Week High
- WORX $4.44
- AWH $3.63
- Technical
- Relative Strength Index (RSI)
- WORX 30.78
- AWH 28.07
- Support Level
- WORX $0.67
- AWH $0.09
- Resistance Level
- WORX $0.79
- AWH $0.36
- Average True Range (ATR)
- WORX 0.05
- AWH 0.01
- MACD
- WORX 0.02
- AWH 0.01
- Stochastic Oscillator
- WORX 9.03
- AWH 15.00
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.